The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals
Abstract
Fragile X syndrome is a frequent cause of mental retardation resulting from the absence of FMRP, the protein encoded by the FMR1 gene. FMRP is an RNA-binding protein of unknown function which is associated with ribosomes. To gain insight into FMRP function, we performed immunolocalization analysis of FMRP truncation and fusion constructs which revealed a nuclear localization signal (NLS) in the amino terminus of FMRP as well as a nuclear export signal (NES) encoded by exon 14. A 17 amino acid peptide containing the FMRP NES, which closely resembles the NES motifs recently described for HIV-1 Rev and PKI, is sufficient to direct nuclear export of a microinjected protein conjugate. Sucrose gradient analysis shows that FMRP ribosome association is RNA-dependent and FMRP is found in ribonucleoprotein (RNP) particles following EDTA treatment. These data are consistent with nascent FMRP entering the nucleus to assemble into mRNP particles prior to export back into the cytoplasm and suggests that fragile X syndrome may result from altered translation of transcripts which normally bind to FMRP.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FMRP is an RNA-binding protein, and, despite its clear shuttling from the nucleus to the cytoplasm (59,60), only the cytoplasmic function of FMRP has been well characterized.”
From Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics (2012) · cites this paper as [59]
Citations
Cites
Verkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90397-h · Cited by 3,481
Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Pieretti, M., Sutcliffe, J. S., Richards, S., Verkert, A. J. M. H., Holden, J. J. A., Fenwick, R. G., Warren, S. T., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90283-5 · Cited by 2,080
Instability of a 550-Base Pair DNA Segment and Abnormal Methylation in Fragile X Syndrome
Oberlé, I., Rousseau, F., Heitz, D., Kretz, C., Devys, D., Hanauer, A., Boué, J., Bertheas, M. F., & Mandel, J. L. (1991) · Science · doi:10.1126/science.252.5009.1097 · Cited by 1,499
Identification of a signal for rapid export of proteins from the nucleus
Wen, W., Meinkotht, J. L., Tsien, R. Y., & Taylor, S. S. (1995) · Cell · doi:10.1016/0092-8674(95)90435-2 · Cited by 1,190
Fischer, U., Huber, J., Boelens, W. C., Mattaj, I. W., & Lührmann, R. (1995) · Cell · doi:10.1016/0092-8674(95)90436-0 · Cited by 1,140
Görlich, D., & Mattaj, I. W. (1996) · Science · doi:10.1126/science.271.5255.1513 · Cited by 1,081
Devys, D., Lutz, Y., Rouyer, N., Bellocq, J., & Mandel, J. (1993) · Nature Genetics · doi:10.1038/ng0893-335 · Cited by 781
FMR1 Protein: Conserved RNP Family Domains and Selective RNA Binding
Ashley, C. T., Wilkinson, K. D., Reines, D., & Warren, S. T. (1993) · Science · doi:10.1126/science.7692601 · Cited by 752
DNA methylation represses FMR-1 transcription in fragile X syndrome
Sutcliffe, J. S., Nelson, D. L., Zhang, F., Pieretti, M., Caskey, C. T., Saxe, D., & Warren, S. T. (1992) · Human Molecular Genetics · doi:10.1093/hmg/1.6.397 · Cited by 680
The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein.
Siomi, H., Siomi, M. C., Nussbaum, R. L., & Dreyfuss, G. (1993) · Cell · doi:10.1016/0092-8674(93)90420-u · Cited by 641
Cited by
Sorted by citations
Items 101–200 of 387
The fragile X syndrome: From molecular genetics to neurobiology
Willemsen, R., Oostra, B. A., Bassell, G. J., & Dictenberg, J. B. (2004) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.20010 · Cited by 106
Garnon, J., Lachance, C., Marco, S. D., Hel, Z., Marion, D., Ruiz, M. C., Newkirk, M. M., Khandjian, É. W., & Radzioch, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401988200 · Cited by 106
Fragile X syndrome: From protein function to therapy
Bagni, C., & Oostra, B. A. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36241 · Cited by 110
Stetler, A., Winograd, C., Sayegh, J., Cheever, A., Patton, E., Zhang, X., Clarke, S. G., & Ceman, S. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi429 · Cited by 103
The fragile X syndrome: exploring its molecular basis and seeking a treatment
Bardoni, B., Davidovic, L., Bensaid, M., & Khandjian, É. W. (2006) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399406010751 · Cited by 106
Nuclear localization of the spinocerebellar ataxia type 7 protein, ataxin-7.
Kaytor, M., Duvick, L., Skinner, P., Koob, M. D., Ranum, L., & Orr, H. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.9.1657 · Cited by 104
Piazzon, N., Rage, F., Schlotter, F., Moine, H., Branlant, C., & Massenet, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707304200 · Cited by 107
Fragile X Mental Retardation Protein FMRP Binds mRNAs in the Nucleus
Kim, M., Bellini, M., & Ceman, S. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01377-08 · Cited by 98
Adinolfi, S., Bagni, C., Musco, G., Gibson, T. J., Mazzarella, L., & Pastore, A. (1999) · RNA · doi:10.1017/s1355838299990647 · Cited by 96
Arginine methylation of RNA‐binding proteins regulates cell function and differentiation
Blackwell, E., & Ceman, S. (2011) · Molecular Reproduction and Development · doi:10.1002/mrd.22024 · Cited by 95
The Fragile X mental retardation protein
Bardoni, B., Schenck, A., & Mandel, J. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00647-5 · Cited by 91
Modulation of dADAR-dependent RNA editing by the Drosophila fragile X mental retardation protein
Bhogal, B., Jepson, J. E. C., Savva, Y. A., Pepper, A. S.-R., Reenan, R. A., & Jongens, T. A. (2011) · Nature Neuroscience · doi:10.1038/nn.2950 · Cited by 87
Moon, J., Beaudin, A. E., Verosky, S. C., Driscoll, L. L., Weiskopf, M., Levitsky, D. A., Crnic, L. S., & Strupp, B. J. (2006) · Behavioral Neuroscience · doi:10.1037/0735-7044.120.6.1367 · Cited by 91
Tamanini, F., van Unen, L., Bakker, C. E., Sacchi, N., GALJAARD, H., Oostra, B. A., & Hoogeveen, A. T. (1999) · Biochemical Journal · doi:10.1042/bj3430517 · Cited by 91
Fragile X syndrome—From genes to cognition
Schneider, A., Hagerman, R. J., & Hessl, D. R. (2009) · Developmental Disabilities Research Reviews · doi:10.1002/ddrr.80 · Cited by 90
Understanding fragile X syndrome: insights from animal models
Bakker, C. E., & Oostra, B. A. (2003) · Cytogenetic and Genome Research · doi:10.1159/000072845 · Cited by 90
Molecular and cellular genetics of fragile X syndrome
Kaufmann, W. E., & Reiss, A. L. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990205)88:1 · Cited by 88
Current perspectives in intronic micro RNAs (miRNAs)
Ying, S., & Lin, S.-L. (2005) · Journal of Biomedical Science · doi:10.1007/s11373-005-9036-8 · Cited by 85
Disordered RNA chaperone proteins: from functions to disease
Iványi-Nagy, R., Davidovic, L., Khandjian, E. W., & Darlix, J. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5100-9 · Cited by 82
Mazrouï, R. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg335 · Cited by 82
Kumari, D., Swaroop, M., Southall, N. T., Huang, W., Zheng, W., & Usdin, K. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0278 · Cited by 83
Comparative Genomic Sequence Analysis of the FXR Gene Family: FMR1, FXR1, and FXR2
Kirkpatrick, L., McIlwain, K. A., & Nelson, D. L. (2001) · Genomics · doi:10.1006/geno.2001.6667 · Cited by 81
Identification of Mouse YB1/p50 as a Component of the FMRP-Associated mRNP Particle
Ceman, S., Nelson, R., & Warren, S. T. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4035 · Cited by 81
Analysis of Domains Affecting Intracellular Localization of the FMRP Protein
Bardoni, B., Sittler, A., Shen, Y., & Mandel, J. (1997) · Neurobiology of Disease · doi:10.1006/nbdi.1997.0142 · Cited by 80
The role of fragile X mental retardation protein in major mental disorders
Fatemi, S. H., & Folsom, T. D. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.11.011 · Cited by 80
Biology of the fragile X mental retardation protein, an RNA-binding protein
Khandjian, É. W. (1999) · Biochemistry and Cell Biology · doi:10.1139/bcb-77-4-331 · Cited by 81
Bardoni, B. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg181 · Cited by 79
Fragile X syndrome at the turn of the century
Kooy, R. F., Willemsen, R., & Oostra, B. A. (2000) · Molecular Medicine Today · doi:10.1016/s1357-4310(00)01674-9 · Cited by 80
Williams syndrome: From genotype through to the cognitive phenotype
Donnai, D., & Karmiloff‐Smith, A. (2000) · American Journal of Medical Genetics · doi:10.1002/1096-8628(200022)97:2 · Cited by 314
Shang, Y., Wang, H., Mercaldo, V., Li, X., Chen, T., & Zhuo, M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06314.x · Cited by 72
The RGG motif proteins: Interactions, functions, and regulations
Chowdhury, M. N., & Jin, H. (2022) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1748 · Cited by 70
Valverde, R., Pozdnyakova, I., Kajander, T., Venkatraman, J., & Regan, L. (2007) · Structure · doi:10.1016/j.str.2007.06.022 · Cited by 75
Fatimy, R. E., Tremblay, S., Dury, A. Y., Solomon, S., Koninck, P. D., Schrader, J. W., & Khandjian, É. W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039338 · Cited by 73
Intrinsic Disorder in Proteins with Pathogenic Repeat Expansions
Darling, A. L., & Uversky, V. N. (2017) · Molecules · doi:10.3390/molecules22122027 · Cited by 75
RNA-Binding Proteins: A Lesson in Repression
Wells, D. G. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1795-06.2006 · Cited by 76
Coffee, R. L., Tessier, C. R., Woodruff, E. A., & Broadie, K. S. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.004598 · Cited by 71
Unmet needs in paediatric psychopharmacology: Present scenario and future perspectives
Persico, A. M., Arango, C., Buitelaar, J. K., Correll, C. U., Glennon, J. C., Hoekstra, P. J., Moreno, C., Vitiello, B., Vorstman, J. A. S., & Zuddas, A. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.06.009 · Cited by 73
Antipsychotic Drug Responsiveness and Dopamine Receptor Signaling; Old Players and New Prospects
Rampino, A., Marakhovskaia, A., Soares-Silva, T., Torretta, S., Veneziani, F., & Beaulieu, J. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00702 · Cited by 72
Tranque, P., Hu, M. C.-Y., Edelman, G. M., & Mauro, V. P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12238 · Cited by 70
Musumeci, S. A., Calabrese, G., Bonaccorso, C. M., D'Antoni, S., Brouwer, J. R., Bakker, C. E., Elia, M., Ferri, R., Nelson, D. L., Oostra, B. A., et al. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2006.08.007 · Cited by 70
Wang, H., Dictenberg, J. B., Ku, L., Li, W., Bassell, G. J., & Feng, Y. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-06-0583 · Cited by 71
Verma, V., Paul, A., Vishwanath, A. A., Vaidya, B., & Clement, J. P. (2019) · Open Biology · doi:10.1098/rsob.180265 · Cited by 68
Tsukahara, F., & Maru, Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308848200 · Cited by 68
Mechanisms of TNFα regulation in uveitis: Focus on RNA-binding proteins
Khera, T. K., Dick, A. D., & Nicholson, L. B. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.08.003 · Cited by 67
Modeling Fragile X Syndrome in Drosophila
Drozd, M. M., Bardoni, B., & Capovilla, M. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00124 · Cited by 70
Ravanidis, S., Kattan, F.-G., & Doxakis, E. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082280 · Cited by 70
Bardoni, B. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00222-2 · Cited by 66
Fragile X mental retardation protein: A paradigm for translational control by RNA-binding proteins
Chen, E., & Joseph, S. (2015) · Biochimie · doi:10.1016/j.biochi.2015.02.005 · Cited by 66
Mutter, M., Wöhr, T., Gioria, S., & Keller, M. (1999) · Biopolymers · doi:10.1002/(sici)1097-0282(1999)51:2 · Cited by 79
Todd, P. K., & Mack, K. J. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00098-x · Cited by 69
Alternative Splicing in the Murine and Human FXR1 Genes
Kirkpatrick, L., McIlwain, K. A., & Nelson, D. L. (1999) · Genomics · doi:10.1006/geno.1999.5868 · Cited by 63
Brackett, D. M., Feng, Q., Amieux, P. S., Sellers, D. L., Horner, P. J., & Morris, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058296 · Cited by 62
Functional Interactions Between microRNAs and RNA Binding Proteins
Jiang, P., & Coller, H. (2012) · MicroRNA e · doi:10.2174/2211536611201010070 · Cited by 62
Drouin, R., Angers, M., Dallaire, N., Rose, T. M., Khandjian, E. W., & Rousseau, F. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.12.2051 · Cited by 62
Tamanini, F. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.10.1487 · Cited by 63
Kim, G., Imam, H., & Siddiqui, A. (2021) · Journal of Virology · doi:10.1128/jvi.00097-21 · Cited by 61
Fähling, M., Mrowka, R., Steege, A., Kirschner, K. M., Benko, E., Förstera, B., Persson, P. B., Thiele, B. J., Meier, J. C., & Scholz, H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807354200 · Cited by 61
FMR1 and Autism, an Intriguing Connection Revisited
Fyke, W., & Velinov, M. T. (2021) · Genes · doi:10.3390/genes12081218 · Cited by 60
Adams-Cioaba, M. A., Guo, Y., Bian, C., Amaya, M. F., Lam, R., Wasney, G. A., Vedadi, M., Xu, C., & Min, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013559 · Cited by 60
Disrupted-in-schizophrenia 1 regulates transport of ITPR1 mRNA for synaptic plasticity
Tsuboi, D., Kuroda, K., Tanaka, M., Namba, T., Iizuka, Y., Taya, S., Shinoda, T., Hikita, T., Muraoka, S., Iizuka, M., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.3984 · Cited by 59
Pharmacology and toxicology of eteplirsen and SRP-5051 for DMD exon 51 skipping: an update
Sheikh, O., & Yokota, T. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-03184-z · Cited by 56
Dubé, M., Huot, M., & Khandjian, É. W. (2000) · BMC Genetics · doi:10.1186/1471-2156-1-4 · Cited by 56
Gene Silencing In Vitro and In Vivo Using Intronic MicroRNAs
Lin, S.-L., & Ying, S. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-083-0_17 · Cited by 55
Hu, Y., Chen, Z., Fu, Y., He, Q., Jiang, L., Zheng, J., Gao, Y., Mei, P., Chen, Z., & Ren, X. (2015) · Nature Communications · doi:10.1038/ncomms7634 · Cited by 59
The fragile X gene and its function
Oostra, B. A., & Chiurazzi, P. (2001) · Clinical Genetics · doi:10.1034/j.1399-0004.2001.600601.x · Cited by 52
Nucleocytoplasmic Traffic of CPEB1 and Accumulation in Crm1 Nucleolar Bodies
Ernoult‐Lange, M., Wilczynska, A., Harper, M., Aigueperse, C., Dautry, F., Kress, M., & Barbieri-Weill, D. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-09-0904 · Cited by 51
Zhou, L., Ye, S.-H., Yang, H., Zhou, Y., Zhao, Q., Sun, W., Gao, M., Yi, Y., & Long, Y. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.02.044 · Cited by 51
Filippini, A., Bonini, D., Lacoux, C., Pacini, L., Zingariello, M., Sancillo, L., Bosisio, D., Salvi, V., Mingardi, J., Via, L. L., et al. (2017) · RNA Biology · doi:10.1080/15476286.2017.1338232 · Cited by 56
De Rubeis, S., Fernández, E., Buzzi, A., Di Marino, D., & Bagni, C. (2012) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-7091-0932-8_23 · Cited by 48
An assessment of screening strategies for fragile X syndrome in the UK
Pembrey, M. E., Barnicoat, A. J., Carmichael, B., Bobrow, M., & TURNER, G. M. (2001) · Health Technology Assessment · doi:10.3310/hta5070 · Cited by 48
The effect of FMR1 CGG repeat interruptions on mutation frequency as measured by sperm typing.
Kunst, C. B., Leeflang, E. P., Iber, J. C., Arnheim, N., & Warren, S. T. (1997) · Journal of Medical Genetics · doi:10.1136/jmg.34.8.627 · Cited by 48
From FMRP Function to Potential Therapies for Fragile X Syndrome
Sethna, F., Moon, C., & Wang, H. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1229-3 · Cited by 49
The microRNA pathway and fragile X mental retardation protein
LI, Y., Lin, L., & Jin, P. (2008) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2008.07.003 · Cited by 49
Come FLY with us: toward understanding fragile X syndrome
Zarnescu, D. C., Shan, G., Warren, S. T., & Jin, P. (2005) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2005.00136.x · Cited by 47
The FRAXopathies: Definition, overview, and update
Pirozzi, F., Tabolacci, E., & Neri, G. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.34113 · Cited by 48
Nuclear Fragile X Mental Retardation Protein Is localized to Cajal Bodies
Dury, A. Y., Fatimy, R. E., Tremblay, S., Rose, T. M., Côté, J., Koninck, P. D., & Khandjian, É. W. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003890 · Cited by 52
Fragile X-related protein family: a double-edged sword in neurodevelopmental disorders and cancer
Majumder, M., Johnson, R. H., & Palanisamy, V. (2020) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2020.1810621 · Cited by 50
The fragile X mental retardation protein interacts with a distinct mRNA nuclear export factor NXF2
Lai, D., Sakkas, D., & Huang, Y. (2006) · RNA · doi:10.1261/rna.94306 · Cited by 46
The RNA-binding Protein Fragile X-related 1 Regulates Somite Formation inXenopus laevis
Huot, M., Bisson, N., Davidovic, L., Mazrouï, R., Labelle, Y., Moss, T., & Khandjian, É. W. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-04-0304 · Cited by 46
Tucker, B., Richards, R. I., & Lardelli, M. T. (2004) · Development Genes and Evolution · doi:10.1007/s00427-004-0438-9 · Cited by 45
Hope, T. J. (1997) · Chemistry & Biology · doi:10.1016/s1074-5521(97)90124-1 · Cited by 45
Sarcoglycans in muscular dystrophy
Hack, A. A., Groh, M. E., & McNally, E. M. (2000) · Microscopy Research and Technique · doi:10.1002/(sici)1097-0029(20000201/15)48:3/4 · Cited by 161
Suhl, J. A., & Warren, S. T. (2015) · Journal of Experimental Neuroscience · doi:10.4137/jen.s25524 · Cited by 43
The Fragile X Protein and Genome Function
Dockendorff, T. C., & Labrador, M. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1122-9 · Cited by 41
Abnormal neuronal morphology and neurochemistry in the auditory brainstem of Fmr1 knockout rats.
Ruby, K., Falvey, K., & Kulesza, R. J. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.06.061 · Cited by 41
Gareau, C., Houssin, É., Martel, D., Coudert, L., Mellaoui, S., Huot, M., Laprise, P., & Mazrouï, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055342 · Cited by 41
The RNA binding protein FMRP: new connections and missing links
Schaeffer, C., Beaulande, M., Ehresmann, C., Ehresmann, B., & Moine, H. (2003) · Biology of the Cell · doi:10.1016/s0248-4900(03)00037-6 · Cited by 44
Prieto, M., Folci, A., & Martin, S. S. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0629-4 · Cited by 44
Harris, M. E., Gontarek, R. R., Derse, D., & Hope, T. J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.3889 · Cited by 40
Using genetic findings in autism for the development of new pharmaceutical compounds
Vorstman, J. A. S., Spooren, W. P. J. M., Persico, A. M., Collier, D. A., Aigner, S., Jagasia, R., Glennon, J. C., & Buitelaar, J. K. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3334-z · Cited by 43
Characterisation of Fmrp in zebrafish: evolutionary dynamics of the fmr1 gene
Padje, S. V. ‘., Engels, B., Blonden, L., Severijnen, L.-A. W. F. M., Verheijen, F. W., Oostra, B. A., & Willemsen, R. (2005) · Development Genes and Evolution · doi:10.1007/s00427-005-0466-0 · Cited by 43
Characterization of DUF724 gene family in Arabidopsis thaliana
Cao, X., Yang, K., Xia, C., Zhang, X.-Q., Chen, L., & Ye, D. (2009) · Plant Molecular Biology · doi:10.1007/s11103-009-9551-5 · Cited by 38
Fan, Y., Yue, J., Xiao, M., Han‐Zhang, H., Wang, Y. V., Ma, C., Deng, Z., Li, Y., Yu, Y., Wang, X., et al. (2017) · eLife · doi:10.7554/elife.26129 · Cited by 42
The Fragile X Mental Retardation Protein in Circadian Rhythmicity and Memory Consolidation
Gatto, C. L., & Broadie, K. S. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8057-0 · Cited by 38
Effect of in vitro promoter methylation and CGG repeat expansion on FMR- 1 expression
Sandberg, G. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.14.2883 · Cited by 38
Calcium Regulates the Nuclear Localization of Protein Arginine Deiminase 2
Li, Z., Nagar, M., Maurais, A. J., Slade, D. J., Parelkar, S. S., Coonrod, S. A., Weerapana, E., & Thompson, P. R. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00225 · Cited by 37
Tissue and developmental regulation of fragile X mental retardation 1 exon 12 and 15 isoforms
Xie, W. Q., Dolzhanskaya, N., LaFauci, G., Dobkin, C., & Denman, R. B. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.03.015 · Cited by 37
Fragile X syndrome, the Fragile X related proteins, and animal models
Hoogeveen, A. T., Willemsen, R., & Oostra, B. A. (2002) · Microscopy Research and Technique · doi:10.1002/jemt.10064 · Cited by 36
Triplet repeat disorders: discussion of molecular mechanisms
Timchenko, L., & Caskey, C. T. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050383 · Cited by 35
Differential increases of specific FMR1 mRNA isoforms in premutation carriers
Pretto, D. I., Eid, J. S., Yrigollen, C. M., Tang, H.-T., Loomis, E. W., Raske, C., Durbin-Johnson, B. P., Hagerman, P. J., & Tassone, F. (2014) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2014-102593 · Cited by 36
Metadata
- Authors
- Eberhart, D.
- Affiliations
- Howard Hughes Medical Institute (US)
- Corresponding author
- Eberhart, D.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 1996-08-01
- Volume
- 5
- Issue
- 8
- Pages
- 1083-1091
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2106239245
- Cited by
- 390
- References
- 53
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 3 · 2023: 4 · 2022: 6 · 2021: 7 · 2020: 7 · 2019: 11 · 2018: 13 · 2017: 10 · 2016: 11 · 2015: 13 · 2014: 17 · 2013: 21 · 2012: 21
- FWCI
- 9.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD 20521)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Keywords
- fragile X syndrome, FMRP, FMR1 gene, nuclear localization signal, nuclear export signal, ribonucleoprotein, RNA-binding proteins, ribosome association, exon 14, protein localization, translational regulation
- MeSH terms
- Amino Acid Sequence, Animals, Biological Transport, Active, Cell Nucleus, Exons, Fragile X Syndrome, Humans, Models, Biological, Molecular Sequence Data, Nerve Tissue Proteins, Recombinant Fusion Proteins, Ribonucleoproteins, Ribosomes, Transfection, RNA-Binding Proteins, COS Cells, Protein Sorting Signals, Fragile X Messenger Ribonucleoprotein 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review